Malaria is a mosquito-borne illness caused by parasites. Malaria people are often suffering from fever, chills and diseases like influenza. In 2016, there were estimated 216 million cases of malaria infection and 445,000 deaths worldwide, most of them are children of Africa. Approximately 1,700 cases of malaria are diagnosed every year in the United States. The majority of cases in the United States are travelers and migrants who return from malaria-infected countries, many of which come from sub-Saharan Africa and South Asia.
The life cycle of malaria parasites is complicated and little is known about the complex immune response to malaria infection. Malaria parasites are also genetically complex and produce thousands of potential antigens. Unlike diseases we currently use in effective vaccines, exposure to malaria parasites does not provide lifelong protection. Acquired immunity can only partially prevent future diseases and malaria infection can last several months without disease symptoms. The initial results of this trial, announced in October 2011, is a promising development for the development of a malaria vaccine for children in Africa and, if successful, can save hundreds of thousands of lives I will. The RTS, S vaccine halves the cases of clinical and severe malaria of vaccinated children
Malaria is caused by parasites of the malaria parasite. The parasites are transmitted to people through an infected female Hamadaka bite called "malaria-mediated virus". Five parasites cause malaria in humans, two of which, Plasmodium falciparum and Plasmodium v ivax are the biggest threats. Malaria is an acute febrile illness. In people who are not immunized, symptoms usually appear after 10 to 15 days after infectious mosquito bites. The first symptoms (fever, headache, chills) may be difficult to identify as malaria. Failure to treat within 24 hours, P. falciparum may develop into a serious disease that usually leads to death